Statement Of Cash Flows [Abstract]

Xspray Pharma - Filing #690673

Concept As at
2022-12-31
2022-01-01 to
2022-12-31
As at
2021-12-31
2021-01-01 to
2021-12-31
As at
2020-12-31
Statement of cash flows [abstract]
Cash flows from (used in) operating activities [abstract]
Interest paid, classified as operating activities
147,000 SEK
4,000 SEK
Interest received, classified as operating activities
1 611 SEK
1 878 SEK
Cash flows from (used in) operating activities
110 179 SEK
51 607 SEK
Cash flows from (used in) investing activities [abstract]
Purchase of property, plant and equipment, classified as investing activities
24 466 SEK
1 313 SEK
Cash flows from (used in) investing activities
135 345 SEK
105 818 SEK
Cash flows from (used in) financing activities [abstract]
Proceeds from issuing shares
100 000 SEK
99 877 SEK
Payments of lease liabilities, classified as financing activities
2 128 SEK
2 154 SEK
Cash flows from (used in) financing activities
93 809 SEK
103 708 SEK
Increase (decrease) in cash and cash equivalents after effect of exchange rate changes
151 715 SEK
53 717 SEK
Cash and cash equivalents
120 166 SEK
271 881 SEK
325 598 SEK

Talk to a Data Expert

Have a question? We'll get back to you promptly.